Ahmed Kotb/daiichisankyo.us
Jul 18, 2026, 20:15
Ahmed Kotb: Exploring Qualitative Platelet Defects
Ahmed Kotb, Head of Global Oncology Medical Affairs at Daiichi Sankyo, shared a post on X:
“Qualitative Platelet Defects
Inherited
- Glanzmann: low GPIIb/IIIa – No aggregation except ristocetin
- Bernard–Soulier: low GPIb – Abnormal ristocetin
- Storage pool disease: Absent 2ry wave
Acquired
- Drugs:Aspirin, Clopidogrel, GP IIb/IIIa inhibitor
- Diseases: Uremia, liver disease”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question